Pharma Reaserch Prod Co Ltd (214450) — Capital Reinvestment Ratio
Pharma Reaserch Prod Co Ltd (214450) has a Capital Reinvestment Ratio of 0.13x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩61.53 Billion) in capital expenditures (₩7.79 Billion). Check how tangible is Pharma Reaserch Prod Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharma Reaserch Prod Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Pharma Reaserch Prod Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 214450 cash flow metrics.
Annual Capital Reinvestment Ratio for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Pharma Reaserch Prod Co Ltd from 2015 to 2025. See how much free cash does Pharma Reaserch Prod Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | ₩183.16 Billion | ₩35.78 Billion | ▼ -29.4% |
| 2024 | 0.28x | ₩139.88 Billion | ₩38.73 Billion | ▲ +36.2% |
| 2023 | 0.20x | ₩64.95 Billion | ₩13.20 Billion | ▼ -32.0% |
| 2022 | 0.30x | ₩59.40 Billion | ₩17.76 Billion | ▼ -5.5% |
| 2021 | 0.32x | ₩65.30 Billion | ₩20.64 Billion | ▼ -70.6% |
| 2020 | 1.07x | ₩32.39 Billion | ₩34.78 Billion | ▲ +115.9% |
| 2019 | 0.50x | ₩19.27 Billion | ₩9.59 Billion | ▼ -91.0% |
| 2018 | 5.50x | ₩5.20 Billion | ₩28.60 Billion | ▲ +516.2% |
| 2017 | 0.89x | ₩8.56 Billion | ₩7.63 Billion | ▲ +271.8% |
| 2016 | 0.24x | ₩8.16 Billion | ₩1.96 Billion | ▲ +730.2% |
| 2015 | 0.03x | ₩16.02 Billion | ₩462.99 Million | — |